Group One Trading, L.P. Biogen Inc. Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

A detailed history of Group One Trading, L.P. transactions in Biogen Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 159,235 shares of BIIB stock, worth $23.7 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares
159,235
Previous 116,653 36.5%
Holding current value
$23.7 Million
Previous $27 Million 14.14%
% of portfolio
1.29%
Previous 0.9%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$189.07 - $236.8 $8.05 Million - $10.1 Million
42,582 Added 36.5%
159,235 $30.9 Million
Q2 2024

Aug 14, 2024
BUY
$190.52 - $236.72 $22.2 Million - $27.6 Million
116,653 New
116,653 $27 Million
Q4 2023

Feb 14, 2024
BUY
$222.59 - $267.94 $787,523 - $947,971
3,538 Added 38.26%
12,786 $3.31 Million
Q3 2023

Nov 09, 2023
SELL
$253.3 - $285.89 $1.78 Million - $2 Million
-7,010 Reduced 43.12%
9,248 $2.38 Million
Q2 2023

Aug 09, 2023
BUY
$275.25 - $318.06 $1.91 Million - $2.21 Million
6,950 Added 74.67%
16,258 $4.63 Million
Q1 2023

May 12, 2023
BUY
$256.56 - $292.34 $2.39 Million - $2.72 Million
9,308 New
9,308 $2.59 Million
Q3 2022

Nov 09, 2022
BUY
$194.69 - $268.46 $6.52 Million - $8.99 Million
33,471 Added 44.69%
108,373 $28.9 Million
Q2 2022

Aug 11, 2022
BUY
$187.54 - $223.02 $3.9 Million - $4.63 Million
20,776 Added 38.38%
74,902 $15.3 Million
Q1 2022

May 12, 2022
BUY
$193.77 - $244.14 $2.2 Million - $2.77 Million
11,355 Added 26.55%
54,126 $11.4 Million
Q4 2021

Feb 11, 2022
BUY
$223.92 - $287.77 $9.58 Million - $12.3 Million
42,771 New
42,771 $10.3 Million
Q2 2021

Aug 10, 2021
SELL
$259.0 - $414.71 $6.77 Million - $10.8 Million
-26,125 Closed
0 $0
Q1 2021

May 12, 2021
SELL
$242.95 - $284.63 $2 Million - $2.34 Million
-8,220 Reduced 23.93%
26,125 $7.31 Million
Q4 2020

Feb 10, 2021
BUY
$236.26 - $355.63 $5.68 Million - $8.55 Million
24,050 Added 233.61%
34,345 $8.41 Million
Q3 2020

Nov 12, 2020
SELL
$264.77 - $305.71 $7.61 Million - $8.78 Million
-28,729 Reduced 73.62%
10,295 $2.92 Million
Q2 2020

Aug 13, 2020
BUY
$258.66 - $342.55 $10.1 Million - $13.4 Million
39,024 New
39,024 $10.4 Million
Q1 2020

May 13, 2020
SELL
$268.85 - $341.04 $2.75 Million - $3.49 Million
-10,226 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$220.06 - $304.07 $2.25 Million - $3.11 Million
10,226 New
10,226 $3.03 Million
Q1 2018

May 11, 2018
SELL
$260.13 - $367.91 $2.75 Million - $3.89 Million
-10,566 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$307.64 - $344.58 $3.25 Million - $3.64 Million
10,566 New
10,566 $3.37 Million
Q3 2017

Nov 15, 2017
SELL
$281.15 - $329.69 $1.12 Million - $1.31 Million
-3,969 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
3,969
3,969 $1.08 Million

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email